Last edition
News about "AGC Biologics"
AGC Biologics to Manufacture Teikoku Seiyaku's rhMMP-7 Drug Substance
AGC Biologics will provide process development and GMP manufacturing services for Teikoku Seiyaku’s rhMMP-7 therapy, supporting development of the novel biologic through its global microbial network in Germany and Japan.
AGC Biologics | 26/05/2026 | By News Bureau
Novelty Nobility Partners with AGC Biologics to Advance Bispecific Drug Candidate
Novelty Nobility partners with AGC Biologics to advance a bispecific Antibody Drug Candidate (ADC) into GMP manufacturing, showcasing Japan’s bioprocessing expertise and AGC Biologics’ global development network.
AGC Biologics | 04/05/2026 | By News Bureau
AGC Biologics’ Milan Cell and Gene Centre of Excellence will support the commercial rollout of Waskyra following US FDA and EU approvals, strengthening treatment options for patients with Wiskott-Aldrich syndrome.
AGC Biologics | 22/01/2026 | By News Bureau | 162
AGC Biologics has partnered with AAVantgarde Bio to manufacture its dual-vector AAV gene therapies targeting inherited retinal disorders. Leveraging the BravoAAV platform, the collaboration aims to advance complex treatments designed to restore vision in patients with genetic blindness.
AGC Biologics | 24/11/2025 | By Dineshwori | 255
AGC Biologics Completes New Manufacturing Site at Copenhagen Campus
AGC Biologics has completed its new manufacturing building at Copenhagen campus.
AGC Biologics | 12/06/2024 | By Aishwarya | 839
AGC Biologics Partners with Asahi Kasei Pharma Corporation on Clinical Antibody Project
AGC Biologics Partners with Asahi Kasei Pharma Corporation on Clinical Antibody Project
AGC Biologics | 18/08/2023 | By Sudeep Soparkar | 535
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy